Epidemiology and management of isolated distal deep venous thrombosis;Thromboses veineuses profondes distales isolées des membres inférieurs : Épidémiologie et prise en charge

Revue de Medecine Interne

Volumn 33, Issue 12, 2012, Pages 678-685

  Galanaud, J P ^a,b   Kahn, S R ^c,d   Khau Van Kien, A ^a   Laroche, J P ^a   Quere I ^a,b  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b UNIV MONTPELLIER   (France)

^c General Hospital   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Calf vein thrombosis; Distal deep vein thrombosis; Epidemiology; Therapeutic management; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT;

ANTICOAGULATION; COMPRESSION STOCKING; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISTAL DEEP VEIN THROMBOSIS; HUMAN; ISOLATED DISTAL DEEP VEIN THROMBOSIS; LEG THROMBOSIS; POSTTHROMBOSIS SYNDROME; PRACTICE GUIDELINE; PROXIMAL DEEP VEIN THROMBOSIS; RISK FACTOR; SHORT SURVEY; TREATMENT DURATION;

ANTICOAGULANTS; HUMANS; LEG; LOWER EXTREMITY; MODELS, BIOLOGICAL; PREVALENCE; RISK FACTORS; VENOUS THROMBOSIS;

EID: 84870248289     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2012.05.012     Document Type: Short Survey

References (52)

1. Galanaud J.P., Bosson J.L., Quere I. Risk factors and early outcomes of patients with symptomatic distal vs. proximal deep-vein thrombosis. Curr Opin Pulm Med 2011, 17:387-391.
2. Righini M. Is it worth diagnosing and treating distal deep vein thrombosis?. J Thromb Haemost 2007, 5:55-59.
3. Schellong S.M. Distal DVT : worth diagnosing? Yes. J Thromb Haemost 2007, 5:51-54.
4. Palareti G., Schellong S. Isolated distal DVT: what we know and what we are doing. J Thromb Haemost 2011, [In press].
5. Masuda E.M., Kistner R.L., Musikasinthorn C., Liquido F., Geling O., He Q. The controversy of managing calf vein thrombosis. J Vasc Surg 2012, 55:550-561.
6. Kearon C., Akl E.A., Comerota A.J., Prandoni P., Bounameaux H., Goldhaber S.Z., et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: american college of chest physicians evidence-based clinical practice guidelines. Chest 2012, 141:419-494.
7. Mismetti P., Baud J.M., Becker F., Belmahdi F., Blanchard P., Constans J., et al. Guidelines for good clinical practice: prevention and treatment of venous thromboembolism in medical patients. J Mal Vasc 2010, 35:127-136.
8. Righini M., Paris S., Le Gal G., Laroche J.P., Perrier A., Bounameaux H. Clinical relevance of distal deep vein thrombosis. Review of literature data. Thromb Haemost 2006, 95:56-64.
9. Caggiati A., Bergan J.J., Gloviczki P., Eklof B., Allegra C., Partsch H. International interdisciplinary consensus committee on venous anatomical terminology. Nomenclature of the veins of the lower limb: extensions, refinements, and clinical application. J Vasc Surg 2005, 41:719-724.
10. Bernardi E., Camporese G., Buller H.R., Siragusa S., Imberti D., Berchio A., et al. Serial 2-point ultrasonography plus D-dimer vs whole-leg color-coded Doppler ultrasonography for diagnosing suspected symptomatic deep vein thrombosis: a randomized controlled trial. JAMA 2008, 300:1653-1659.
11. Gibson N.S., Schellong S.M., Kheir D.Y., Beyer-Westendorf J., Gallus A.S., McRae S., et al. Safety and sensitivity of two ultrasound strategies in patients with clinically suspected deep venous thrombosis: a prospective management study. J Thromb Haemost 2009, 7:2035-2041.
12. Palareti G., Cosmi B., Lessiani G., Rodorigo G., Guazzaloca G., Brusi C., et al. Evolution of untreated calf deep-vein thrombosis in high risk symptomatic outpatients: the blind, prospective CALTHRO study. Thromb Haemost 2010, 104:1063-1070.
13. Buller H.R., Cohen A.T., Davidson B., Decousus H., Gallus A.S., Gent M., et al. Idraparinux versus standard therapy for venous thromboembolic disease. N Engl J Med 2007, 357:1094-1104.
14. Macdonald P.S., Kahn S.R., Miller N., Obrand D. Short-term natural history of isolated gastrocnemius and soleal vein thrombosis. J Vasc Surg 2003, 37:523-527.
15. Schwarz T., Buschmann L., Beyer J., Halbritter K., Rastan A., Schellong S. Therapy of isolated calf muscle vein thrombosis: a randomized, controlled study. J Vasc Surg 2010, 52:1246-1250.
16. News ID. Calf surveillance is no longer an option. IAC Newsletter. 2008;Summer; Sect. 8-9.
17. Oger E. Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study group. Groupe d'étude de la thrombose de Bretagne occidentale. Thromb Haemost 2000, 83:657-660.
18. Johnson S.A., Stevens S.M., Woller S.C., Lake E., Donadini M., Cheng J., et al. Risk of deep vein thrombosis following a single negative whole-leg compression ultrasound: a systematic review and meta-analysis. JAMA 2010, 303:438-445.
19. Palareti G., Agnelli G., Imberti D., Moia M., Ageno W., Pistelli R., et al. A commentary: to screen for calf DVT or not to screen? The highly variable practice among Italian centers highlights this important and still unresolved clinical option. Results from the Italian MASTER registry. Thromb Haemost 2008, 99:241-244.
20. Galanaud J.P., Quenet S., Rivron-Guillot K., Quere I., Sanchez Munoz-Torrero J.F., Tolosa C., et al. Comparison of the clinical history of symptomatic isolated distal deep-vein thrombosis vs. proximal deep vein thrombosis in 11 086 patients. J Thromb Haemost 2009, 7:2028-2034.
21. Galanaud J.P., Sevestre-Pietri M.A., Bosson J.L., Laroche J.P., Righini M., Brisot D., et al. Comparative study on risk factors and early outcome of symptomatic distal versus proximal deep vein thrombosis: results from the OPTIMEV study. Thromb Haemost 2009, 102:493-500.
22. Galanaud J.P., Sevestre M.A., Genty C., Laroche J.P., Zizka V., Quere I., et al. Comparison of the clinical history of symptomatic isolated muscular calf vein thrombosis versus deep calf vein thrombosis. J Vasc Surg 2010, 52:932-938. [938.e1-2].
23. Oger E., Bressollette L., Nonent M., Lacut K., Guias B., Couturaud F., et al. High prevalence of asymptomatic deep vein thrombosis on admission in a medical unit among elderly patients. Thromb Haemost 2002, 88:592-597.
24. Cogo A., Lensing A.W., Prandoni P., Hirsh J. Distribution of thrombosis in patients with symptomatic deep vein thrombosis. Implications for simplifying the diagnostic process with compression ultrasound. Arch Intern Med 1993, 153:2777-2780.
25. Barritt D.W., Jordan S.C. Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet 1960, 1:1309-1312.
26. Lagerstedt C.I., Olsson C.G., Fagher B.O., Oqvist B.W., Albrechtsson U. Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis. Lancet 1985, 2:515-518.
27. Schwarz T., Schmidt B., Beyer J., Schellong S.M. Therapy of isolated calf muscle vein thrombosis with low-molecular-weight heparin. Blood Coagul Fibrinolysis 2001, 12:597-599.
28. Lautz T.B., Abbas F., Walsh S.J., Chow C., Amaranto D.J., Wang E., et al. Isolated gastrocnemius and soleal vein thrombosis: should these patients receive therapeutic anticoagulation?. Ann Surg 2010, 251:735-742.
29. Quere I., Righini M. Ultrasound-based diagnostic strategies for deep vein thrombosis. JAMA 2009, 301:933. [author reply 4-5].
30. Singh K., Yakoub D., Giangola P., DeCicca M., Patel C.A., Marzouk F., et al. Early follow-up and treatment recommendations for isolated calf deep venous thrombosis. J Vasc Surg 2012, 55:136-140.
31. Quéré I., Galanaud J.P., Becker F., Laroche J.P., Righini M., Lévesque H. Distal deep-venous thrombosis: diagnostic and therapeutic issues. Rev Med Interne 2008, 29:491-497.
32. McIlrath S.T., Blaivas M., Lyon M. Patient follow-up after negative lower extremity bedside ultrasound for deep venous thrombosis in the ED. Am J Emerg Med 2006, 24:325-328.
33. Elias A., Mallard L., Elias M., Alquier C., Guidolin F., Gauthier B., et al. A single complete ultrasound investigation of the venous network for the diagnostic management of patients with a clinically suspected first episode of deep venous thrombosis of the lower limbs. Thromb Haemost 2003, 89:221-227.
34. Luxembourg B.S.J., Hecking C., Schindewolf M., Zgouras D., Lehmeyer S., Lindhoff-Last E. Performance of five D-dimer assays for the exclusion of symptomatic distal leg vein thrombosis. Thromb Haemost 2012, 107:369-378.
35. Vaitkus P.T., Leizorovicz A., Cohen A.T., Turpie A.G., Olsson C.G., Goldhaber S.Z. Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients. Thromb Haemost 2005, 93:76-79.
36. Seinturier C., Bosson J.L., Colonna M., Imbert B., Carpentier P.H. Site and clinical outcome of deep vein thrombosis of the lower limbs: an epidemiological study. J Thromb Haemost 2005, 3:1362-1367.
37. Pinede L., Ninet J., Duhaut P., Chabaud S., Demolombe-Rague S., Durieu I., et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation 2001, 103:2453-2460.
38. Boutitie F., Pinede L., Schulman S., Agnelli G., Raskob G., Julian J., et al. Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials. BMJ 2011, 342:d3036.
39. Baglin T., Douketis J., Tosetto A., Marcucci M., Cushman M., Kyrle P., et al. Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient-level meta-analysis. J Thromb Haemost 2010, 8:2436-2442.
40. Kahn S.R. How I treat post-thrombotic syndrome. Blood 2009, 114:4624-4631.
41. Kahn S.R., Shbaklo H., Lamping D.L., Holcroft C.A., Shrier I., Miron M.J., et al. Determinants of health-related quality of life during the 2 years following deep vein thrombosis. J Thromb Haemost 2008, 6:1105-1112.
42. Guanella R., Ducruet T., Johri M., Miron M.J., Roussin A., Desmarais S., et al. Economic burden and cost determinants of deep venous thrombosis during two years following diagnosis: a prospective evaluation. J Thromb Haemost 2011, 9:2397-2405.
43. Ruppert A., Steinle T., Lees M. Economic burden of venous thromboembolism: a systematic review. J Med Econ 2011, 14:65-74.
44. Tick L.W., Kramer M.H., Rosendaal F.R., Faber W.R., Doggen C.J. Risk factors for post-thrombotic syndrome in patients with a first deep venous thrombosis. J Thromb Haemost 2008, 6:2075-2081.
45. Carrier M., Le Gal G., Wells P.S., Fergusson D., Ramsay T., Rodger M.A. Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism?. Ann Intern Med 2008, 149:323-333.
46. Bura A., Cailleux N., Bienvenu B., Léger P., Bissery A., Boccalon H., et al. Incidence and prognosis of cancer associated with bilateral venous thrombosis: a prospective study of 103 patients. J Thromb Haemost 2004, 2:441-444.
47. Parisi R., Visonà A., Camporese G., Verlato F., Lessiani G., Antignani P.L., et al. Isolated distal deep vein thrombosis: efficacy and safety of a protocol of treatment. Treatment of Isolated Calf Thrombosis (TICT) Study. Int Angiol 2009, 28:68-72.
48. Landefeld C.S. Noninvasive diagnosis of deep vein thrombosis. JAMA 2008, 300:1696-1697.
49. Schulman S., Rhedin A.S., Lindmarker P., Carlsson A., Larfars G., Nicol P., et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N Engl J Med 1995, 332:1661-1665.
50. Lohr J.M., James K.V., Deshmukh R.M., Hasselfeld K.A. Calf vein thrombi are not a benign finding. Am J Surg 1995, 170:86-90. [Allastair B. Karmody Award].
51. Masuda E.M., Kessler D.M., Kistner R.L., Eklof B., Sato D.T. The natural history of calf vein thrombosis: lysis of thrombi and development of reflux. J Vasc Surg 1998, 28:67-73.
52. Labropoulos N., Kang S.S., Mansour M.A., Giannoukas A.D., Moutzouros V., Baker W.H. Early thrombus remodelling of isolated calf deep vein thrombosis. Eur J Vasc Endovasc Surg 2002, 23:344-348.